Alpha 2.0
Login Register
» Authors » Prue Weideman

Prue Weideman

Explore the profile of Prue Weideman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 72
Followers 0
Related Specialties
Oncology
Public Health
Psychology
Top 10 Co-Authors
Kelly-Anne Phillips
John L Hopper
Antonis C Antoniou
Phyllis Butow
Mark A Jenkins
Adrian Bickerstaffe
Mathias Bressel
Jack Cuzick
Ian M Collins
Emma Steel
Published In
Breast Cancer Res Treat
Aust N Z J Obstet Gynaecol
Am J Epidemiol
J Clin Oncol
Psychooncology
Affiliations
Soon will be listed here.
Recent Articles
1.
The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing
Lo L, Collins I, Bressel M, Butow P, Emery J, Keogh L, et al.
JMIR Form Res . 2019 Jan; 2(2):e24. PMID: 30684421
Background: iPrevent estimates breast cancer (BC) risk and provides tailored risk management information. Objective: The objective of this study was to assess the usability and acceptability of the iPrevent prototype....
2.
Does stress increase risk of breast cancer? A 15-year prospective study
Butow P, Price M, Coll J, Tucker K, Meiser B, Milne R, et al.
Psychooncology . 2018 Apr; 27(8):1908-1914. PMID: 29677398
Objective: The possible impact of stress on cancer incidence remains controversial. We prospectively evaluated associations between life event stressors, social support, personality characteristics (optimism, anger control, antiemotionality), and risk of...
3.
Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer
Dite G, MacInnis R, Bickerstaffe A, Dowty J, Milne R, Antoniou A, et al.
Am J Epidemiol . 2017 Apr; 185(6):487-500. PMID: 28399571
The ability to classify people according to their underlying genetic susceptibility to a disease is increasing with new knowledge, better family data, and more sophisticated risk prediction models, allowing for...
4.
iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management
Collins I, Bickerstaffe A, Ranaweera T, Maddumarachchi S, Keogh L, Emery J, et al.
Breast Cancer Res Treat . 2016 Feb; 156(1):171-82. PMID: 26909793
We aimed to develop a user-centered, web-based, decision support tool for breast cancer risk assessment and personalized risk management. Using a novel model choice algorithm, iPrevent(®) selects one of two...
5.
Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)
Kiely B, Jenkins M, McKinley J, Friedlander M, Weideman P, Milne R, et al.
Breast Cancer Res Treat . 2009 Aug; 120(3):715-23. PMID: 19669874
The purpose of this study is to determine the prevalence and predictors of contralateral risk-reducing mastectomy (CRRM) in Australasian women at high familial risk of a second primary breast cancer...
6.
Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer
Dawson S, Price M, Jenkins M, McKinley J, Butow P, McLachlan S, et al.
J Clin Oncol . 2007 Nov; 26(2):225-32. PMID: 18040054
Purpose: Women from BRCA mutation-positive families who do not carry the family-specific mutation are generally at average cancer risk and therefore do not require intensive risk management. Methods: Participants were...
7.
Randomised trial of an integrated educational strategy to reduce investigation rates in young women with dysfunctional uterine bleeding
Searle J, Grover S, Santin A, Weideman P
Aust N Z J Obstet Gynaecol . 2002 Oct; 42(4):395-400. PMID: 12403289
Objectives: To assess the effectiveness of an integrated educational strategy to change clinician behaviour and reduce the number of hysteroscopies and/or dilatation and curettages for women 40 years or less...